Stephanie R. Oatman, J. Reddy, Amin Atashgaran, X. Wang, Yuhao Min, Zachary Quicksall, Floor Vanelderen, Minerva M. Carrasquillo, Chia‐Chen Liu, Yu Yamazaki, T. Nguyen, Michael Heckman, Na Zhao, Michael DeTure, Melissa E. Murray, GuoJun Bu, Takahisa Kanekiyo, Dennis W. Dickson, Mariet Allen, Nilüfer Ertekin-Taner
Alzheimer’s disease (AD) brains have variable neuropathologic and biochemical changes. Capturing epigenetic factors associated with this variability can reveal novel biological insights into AD pathophysiology. Here, we conduct an epigenome-wide association study of DNA methylation in 472 AD brains with neuropathologic and biochemical brain protein levels core to AD pathogenesis. Using a novel regional methylation (rCpGm) approach, we identify 5478 significant associations, 99.7% of which associate with tau biochemical measures, and 93 concordant associations in external datasets. Transcriptome-methylome integration reveals enrichment in oligodendrocyte genes, including known AD risk gene BIN1, myelination genes MYRF, MBP and MAG previously implicated in AD, and novel genes like LDB3. Further characterization of these perturbations in independent AD and primary tauopathy datasets highlights consistent tau-related associations. In summary, we uncover the integrative epigenomic landscape of AD, demonstrate tau-related oligodendrocyte gene perturbations as a common potential pathomechanism across tauopathies and share findings via our Multiomic Atlas. Here the authors perform an epigenome-wide DNAm study in 472 AD brains, identifying 5,478 regional methylation associations, mainly with tau. Replication and integration analyses reveal 93 regions and 535 genes enriched in oligodendrocyte genes, a subset of which were consistent across tauopathies.